Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
View All Featured ArticlesHeadline News
FDA grants accelerated approval to Nelkarmi for previously treated ALK-positive lung cancer
FDA clears expanded ENT indication for Johnson & Johnson’s HARMONIC 1100 Shears
KarXT shows preliminary symptom improvements in Phase III Alzheimer’s psychosis studies
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Single-Use & Stainless Steel BioReactors: Quality Factors for Consideration When Selecting a Suitable System
Presented by Dr Trevor Deeks, Principal and Consultant of Deeks Pharmaceutical Consulting Services, LLC
08th November 2017
Development and Implementation of Intensified Bioprocessing for Biologics Manufacturing
Presented by Hang Zhou, Ph.D., Vice President, Head of Cell Culture Process Development Biologics and Bioprocess Dept. at WuXi Biologics
12th March 2021
Continuous Manufacturing as a Default Platform for Oral Solid Drug Products
Presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson and Bob Lenich, Director of Life Sciences Business at Emerson
19th May 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















